You Searched For "Novo Nordisk"

Novo Nordisk's obesity drug can reduce heart problem risk by 20%:...

Novo Nordisk's obesity drug semaglutide (marketed as Wegovy) can significantly reduce risk of major adverse cardiovascular events (MACE) by 20 per...